German S3-guidelines on the treatment of psoriasis vulgaris (short version)
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of...
Gespeichert in:
| Veröffentlicht in: | Archives of Dermatological Research 2012-03, Vol.304 (2), p.87-113 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 113 |
|---|---|
| container_issue | 2 |
| container_start_page | 87 |
| container_title | Archives of Dermatological Research |
| container_volume | 304 |
| creator | Nast, A. Boehncke, W. H. Mrowietz, U. Ockenfels, H. M. Philipp, S. Reich, K. Rosenbach, T. Sammain, A. Schlaeger, M. Sebastian, M. Sterry, W. Streit, V. Augustin, M. Erdmann, R. Klaus, J. Koza, J. Müller, S. Orzechowski, H. D. Rosumeck, S. Schmid-Ott, G. Weberschock, T. Rzany, B. |
| description | Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, patient surveys have revealed insufficient satisfaction with the efficacy of available treatments and a high rate of medication non-compliance (Richards et al. in J Am Acad Dermatol 41(4):581–583,
1999
). To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis first published in 2006 and now updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate, and severe plaque-type psoriasis in adults. This short version of the guidelines presents the resulting series of therapeutic recommendations, which were based on a systematic literature search and discussed and approved by a team of dermatology experts. In addition to the therapeutic recommendations provided in this short version, the full version of the guidelines includes information on contraindications, adverse events, drug interactions, practicality, and costs, as well as detailed information on how best to apply the treatments described (for full version please see Nast et al. in JDDG Suppl 2:S1–S104,
2011
or
http://www.psoriasis-leitlinie.de
). |
| doi_str_mv | 10.1007/s00403-012-1214-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_923579120</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1008848168</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-b50c66ba68036b03cba3797bab363ac3b251f7db5b7d8f16c09326159c27af253</originalsourceid><addsrcrecordid>eNp9kUFLwzAUx4Mobsx9AC9SvDgP0ZekTZqjDJ3iwIMK3krSpVtH28ykHfjtzehUEDSXBN4vv8d7f4ROCVwRAHHtAWJgGAjFhJIYpwdoSGJGMXD5doiGwGLAjEs-QGPv1xCOgJiCOEYDSlkCRMghepwZV6smemZ42ZULU5WN8ZFtonZlotYZ1damaSNbRBtvXal86aNtVy2VC4-JX1nXRlvjfGmbyxN0VKjKm_H-HqHXu9uX6T2eP80epjdznMdctlgnkHOuFU-BcQ0s14oJKbTSjDOVM00TUoiFTrRYpAXhOUhGOUlkToUqaMJG6KL3bpx974xvs7r0uakq1Rjb-UyG6YQkFAI5-ZcMi0zTOCU8Dej5L3RtO9eEOYKPpjKBRAaI9FDurPfOFNnGlbVyH8G0k4msTyULqWS7VLKd-Gwv7nRtFt8_vjIIAO0BH0rN0rifzn9bPwHPYpVJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>922895059</pqid></control><display><type>article</type><title>German S3-guidelines on the treatment of psoriasis vulgaris (short version)</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Nast, A. ; Boehncke, W. H. ; Mrowietz, U. ; Ockenfels, H. M. ; Philipp, S. ; Reich, K. ; Rosenbach, T. ; Sammain, A. ; Schlaeger, M. ; Sebastian, M. ; Sterry, W. ; Streit, V. ; Augustin, M. ; Erdmann, R. ; Klaus, J. ; Koza, J. ; Müller, S. ; Orzechowski, H. D. ; Rosumeck, S. ; Schmid-Ott, G. ; Weberschock, T. ; Rzany, B.</creator><creatorcontrib>Nast, A. ; Boehncke, W. H. ; Mrowietz, U. ; Ockenfels, H. M. ; Philipp, S. ; Reich, K. ; Rosenbach, T. ; Sammain, A. ; Schlaeger, M. ; Sebastian, M. ; Sterry, W. ; Streit, V. ; Augustin, M. ; Erdmann, R. ; Klaus, J. ; Koza, J. ; Müller, S. ; Orzechowski, H. D. ; Rosumeck, S. ; Schmid-Ott, G. ; Weberschock, T. ; Rzany, B. ; Deutsche Dermatologische Gesellschaft ; Berufsverband Deutscher Dermatologen</creatorcontrib><description>Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, patient surveys have revealed insufficient satisfaction with the efficacy of available treatments and a high rate of medication non-compliance (Richards et al. in J Am Acad Dermatol 41(4):581–583,
1999
). To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis first published in 2006 and now updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate, and severe plaque-type psoriasis in adults. This short version of the guidelines presents the resulting series of therapeutic recommendations, which were based on a systematic literature search and discussed and approved by a team of dermatology experts. In addition to the therapeutic recommendations provided in this short version, the full version of the guidelines includes information on contraindications, adverse events, drug interactions, practicality, and costs, as well as detailed information on how best to apply the treatments described (for full version please see Nast et al. in JDDG Suppl 2:S1–S104,
2011
or
http://www.psoriasis-leitlinie.de
).</description><identifier>ISSN: 0340-3696</identifier><identifier>EISSN: 1432-069X</identifier><identifier>DOI: 10.1007/s00403-012-1214-8</identifier><identifier>PMID: 22350179</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adult ; Clinical Protocols ; Dermatology ; Diagnosis, Differential ; Drug interaction ; Drug Therapy ; Evidence-Based Medicine ; Expert Testimony ; Germany ; Guideline ; Humans ; Inflammatory diseases ; Medicine ; Medicine & Public Health ; Patient Compliance ; Patient Satisfaction ; Psoriasis - diagnosis ; Psoriasis - epidemiology ; Psoriasis - physiopathology ; Psoriasis - therapy ; psoriasis vulgaris ; PUVA Therapy ; Quality of Life ; Skin - pathology ; Skin diseases</subject><ispartof>Archives of Dermatological Research, 2012-03, Vol.304 (2), p.87-113</ispartof><rights>Springer-Verlag 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-b50c66ba68036b03cba3797bab363ac3b251f7db5b7d8f16c09326159c27af253</citedby><cites>FETCH-LOGICAL-c469t-b50c66ba68036b03cba3797bab363ac3b251f7db5b7d8f16c09326159c27af253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00403-012-1214-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00403-012-1214-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22350179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nast, A.</creatorcontrib><creatorcontrib>Boehncke, W. H.</creatorcontrib><creatorcontrib>Mrowietz, U.</creatorcontrib><creatorcontrib>Ockenfels, H. M.</creatorcontrib><creatorcontrib>Philipp, S.</creatorcontrib><creatorcontrib>Reich, K.</creatorcontrib><creatorcontrib>Rosenbach, T.</creatorcontrib><creatorcontrib>Sammain, A.</creatorcontrib><creatorcontrib>Schlaeger, M.</creatorcontrib><creatorcontrib>Sebastian, M.</creatorcontrib><creatorcontrib>Sterry, W.</creatorcontrib><creatorcontrib>Streit, V.</creatorcontrib><creatorcontrib>Augustin, M.</creatorcontrib><creatorcontrib>Erdmann, R.</creatorcontrib><creatorcontrib>Klaus, J.</creatorcontrib><creatorcontrib>Koza, J.</creatorcontrib><creatorcontrib>Müller, S.</creatorcontrib><creatorcontrib>Orzechowski, H. D.</creatorcontrib><creatorcontrib>Rosumeck, S.</creatorcontrib><creatorcontrib>Schmid-Ott, G.</creatorcontrib><creatorcontrib>Weberschock, T.</creatorcontrib><creatorcontrib>Rzany, B.</creatorcontrib><creatorcontrib>Deutsche Dermatologische Gesellschaft</creatorcontrib><creatorcontrib>Berufsverband Deutscher Dermatologen</creatorcontrib><title>German S3-guidelines on the treatment of psoriasis vulgaris (short version)</title><title>Archives of Dermatological Research</title><addtitle>Arch Dermatol Res</addtitle><addtitle>Arch Dermatol Res</addtitle><description>Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, patient surveys have revealed insufficient satisfaction with the efficacy of available treatments and a high rate of medication non-compliance (Richards et al. in J Am Acad Dermatol 41(4):581–583,
1999
). To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis first published in 2006 and now updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate, and severe plaque-type psoriasis in adults. This short version of the guidelines presents the resulting series of therapeutic recommendations, which were based on a systematic literature search and discussed and approved by a team of dermatology experts. In addition to the therapeutic recommendations provided in this short version, the full version of the guidelines includes information on contraindications, adverse events, drug interactions, practicality, and costs, as well as detailed information on how best to apply the treatments described (for full version please see Nast et al. in JDDG Suppl 2:S1–S104,
2011
or
http://www.psoriasis-leitlinie.de
).</description><subject>Adult</subject><subject>Clinical Protocols</subject><subject>Dermatology</subject><subject>Diagnosis, Differential</subject><subject>Drug interaction</subject><subject>Drug Therapy</subject><subject>Evidence-Based Medicine</subject><subject>Expert Testimony</subject><subject>Germany</subject><subject>Guideline</subject><subject>Humans</subject><subject>Inflammatory diseases</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Patient Compliance</subject><subject>Patient Satisfaction</subject><subject>Psoriasis - diagnosis</subject><subject>Psoriasis - epidemiology</subject><subject>Psoriasis - physiopathology</subject><subject>Psoriasis - therapy</subject><subject>psoriasis vulgaris</subject><subject>PUVA Therapy</subject><subject>Quality of Life</subject><subject>Skin - pathology</subject><subject>Skin diseases</subject><issn>0340-3696</issn><issn>1432-069X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUFLwzAUx4Mobsx9AC9SvDgP0ZekTZqjDJ3iwIMK3krSpVtH28ykHfjtzehUEDSXBN4vv8d7f4ROCVwRAHHtAWJgGAjFhJIYpwdoSGJGMXD5doiGwGLAjEs-QGPv1xCOgJiCOEYDSlkCRMghepwZV6smemZ42ZULU5WN8ZFtonZlotYZ1damaSNbRBtvXal86aNtVy2VC4-JX1nXRlvjfGmbyxN0VKjKm_H-HqHXu9uX6T2eP80epjdznMdctlgnkHOuFU-BcQ0s14oJKbTSjDOVM00TUoiFTrRYpAXhOUhGOUlkToUqaMJG6KL3bpx974xvs7r0uakq1Rjb-UyG6YQkFAI5-ZcMi0zTOCU8Dej5L3RtO9eEOYKPpjKBRAaI9FDurPfOFNnGlbVyH8G0k4msTyULqWS7VLKd-Gwv7nRtFt8_vjIIAO0BH0rN0rifzn9bPwHPYpVJ</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Nast, A.</creator><creator>Boehncke, W. H.</creator><creator>Mrowietz, U.</creator><creator>Ockenfels, H. M.</creator><creator>Philipp, S.</creator><creator>Reich, K.</creator><creator>Rosenbach, T.</creator><creator>Sammain, A.</creator><creator>Schlaeger, M.</creator><creator>Sebastian, M.</creator><creator>Sterry, W.</creator><creator>Streit, V.</creator><creator>Augustin, M.</creator><creator>Erdmann, R.</creator><creator>Klaus, J.</creator><creator>Koza, J.</creator><creator>Müller, S.</creator><creator>Orzechowski, H. D.</creator><creator>Rosumeck, S.</creator><creator>Schmid-Ott, G.</creator><creator>Weberschock, T.</creator><creator>Rzany, B.</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20120301</creationdate><title>German S3-guidelines on the treatment of psoriasis vulgaris (short version)</title><author>Nast, A. ; Boehncke, W. H. ; Mrowietz, U. ; Ockenfels, H. M. ; Philipp, S. ; Reich, K. ; Rosenbach, T. ; Sammain, A. ; Schlaeger, M. ; Sebastian, M. ; Sterry, W. ; Streit, V. ; Augustin, M. ; Erdmann, R. ; Klaus, J. ; Koza, J. ; Müller, S. ; Orzechowski, H. D. ; Rosumeck, S. ; Schmid-Ott, G. ; Weberschock, T. ; Rzany, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-b50c66ba68036b03cba3797bab363ac3b251f7db5b7d8f16c09326159c27af253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Clinical Protocols</topic><topic>Dermatology</topic><topic>Diagnosis, Differential</topic><topic>Drug interaction</topic><topic>Drug Therapy</topic><topic>Evidence-Based Medicine</topic><topic>Expert Testimony</topic><topic>Germany</topic><topic>Guideline</topic><topic>Humans</topic><topic>Inflammatory diseases</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Patient Compliance</topic><topic>Patient Satisfaction</topic><topic>Psoriasis - diagnosis</topic><topic>Psoriasis - epidemiology</topic><topic>Psoriasis - physiopathology</topic><topic>Psoriasis - therapy</topic><topic>psoriasis vulgaris</topic><topic>PUVA Therapy</topic><topic>Quality of Life</topic><topic>Skin - pathology</topic><topic>Skin diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nast, A.</creatorcontrib><creatorcontrib>Boehncke, W. H.</creatorcontrib><creatorcontrib>Mrowietz, U.</creatorcontrib><creatorcontrib>Ockenfels, H. M.</creatorcontrib><creatorcontrib>Philipp, S.</creatorcontrib><creatorcontrib>Reich, K.</creatorcontrib><creatorcontrib>Rosenbach, T.</creatorcontrib><creatorcontrib>Sammain, A.</creatorcontrib><creatorcontrib>Schlaeger, M.</creatorcontrib><creatorcontrib>Sebastian, M.</creatorcontrib><creatorcontrib>Sterry, W.</creatorcontrib><creatorcontrib>Streit, V.</creatorcontrib><creatorcontrib>Augustin, M.</creatorcontrib><creatorcontrib>Erdmann, R.</creatorcontrib><creatorcontrib>Klaus, J.</creatorcontrib><creatorcontrib>Koza, J.</creatorcontrib><creatorcontrib>Müller, S.</creatorcontrib><creatorcontrib>Orzechowski, H. D.</creatorcontrib><creatorcontrib>Rosumeck, S.</creatorcontrib><creatorcontrib>Schmid-Ott, G.</creatorcontrib><creatorcontrib>Weberschock, T.</creatorcontrib><creatorcontrib>Rzany, B.</creatorcontrib><creatorcontrib>Deutsche Dermatologische Gesellschaft</creatorcontrib><creatorcontrib>Berufsverband Deutscher Dermatologen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of Dermatological Research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nast, A.</au><au>Boehncke, W. H.</au><au>Mrowietz, U.</au><au>Ockenfels, H. M.</au><au>Philipp, S.</au><au>Reich, K.</au><au>Rosenbach, T.</au><au>Sammain, A.</au><au>Schlaeger, M.</au><au>Sebastian, M.</au><au>Sterry, W.</au><au>Streit, V.</au><au>Augustin, M.</au><au>Erdmann, R.</au><au>Klaus, J.</au><au>Koza, J.</au><au>Müller, S.</au><au>Orzechowski, H. D.</au><au>Rosumeck, S.</au><au>Schmid-Ott, G.</au><au>Weberschock, T.</au><au>Rzany, B.</au><aucorp>Deutsche Dermatologische Gesellschaft</aucorp><aucorp>Berufsverband Deutscher Dermatologen</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>German S3-guidelines on the treatment of psoriasis vulgaris (short version)</atitle><jtitle>Archives of Dermatological Research</jtitle><stitle>Arch Dermatol Res</stitle><addtitle>Arch Dermatol Res</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>304</volume><issue>2</issue><spage>87</spage><epage>113</epage><pages>87-113</pages><issn>0340-3696</issn><eissn>1432-069X</eissn><abstract>Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Patients afflicted with severe psoriasis vulgaris may experience a significant reduction in quality of life. Despite the large variety of treatment options available, patient surveys have revealed insufficient satisfaction with the efficacy of available treatments and a high rate of medication non-compliance (Richards et al. in J Am Acad Dermatol 41(4):581–583,
1999
). To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft (DDG) and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis first published in 2006 and now updated in 2011. The Guidelines focus on induction therapy in cases of mild, moderate, and severe plaque-type psoriasis in adults. This short version of the guidelines presents the resulting series of therapeutic recommendations, which were based on a systematic literature search and discussed and approved by a team of dermatology experts. In addition to the therapeutic recommendations provided in this short version, the full version of the guidelines includes information on contraindications, adverse events, drug interactions, practicality, and costs, as well as detailed information on how best to apply the treatments described (for full version please see Nast et al. in JDDG Suppl 2:S1–S104,
2011
or
http://www.psoriasis-leitlinie.de
).</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>22350179</pmid><doi>10.1007/s00403-012-1214-8</doi><tpages>27</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0340-3696 |
| ispartof | Archives of Dermatological Research, 2012-03, Vol.304 (2), p.87-113 |
| issn | 0340-3696 1432-069X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_923579120 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Adult Clinical Protocols Dermatology Diagnosis, Differential Drug interaction Drug Therapy Evidence-Based Medicine Expert Testimony Germany Guideline Humans Inflammatory diseases Medicine Medicine & Public Health Patient Compliance Patient Satisfaction Psoriasis - diagnosis Psoriasis - epidemiology Psoriasis - physiopathology Psoriasis - therapy psoriasis vulgaris PUVA Therapy Quality of Life Skin - pathology Skin diseases |
| title | German S3-guidelines on the treatment of psoriasis vulgaris (short version) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T15%3A50%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=German%20S3-guidelines%20on%20the%20treatment%20of%20psoriasis%20vulgaris%20(short%20version)&rft.jtitle=Archives%20of%20Dermatological%20Research&rft.au=Nast,%20A.&rft.aucorp=Deutsche%20Dermatologische%20Gesellschaft&rft.date=2012-03-01&rft.volume=304&rft.issue=2&rft.spage=87&rft.epage=113&rft.pages=87-113&rft.issn=0340-3696&rft.eissn=1432-069X&rft_id=info:doi/10.1007/s00403-012-1214-8&rft_dat=%3Cproquest_cross%3E1008848168%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=922895059&rft_id=info:pmid/22350179&rfr_iscdi=true |